GEA
RGEN icon

Glen Eagle Advisors’s Repligen RGEN Stock Holding History

Glen Eagle Advisors’s Portfolio RGEN Stock Details RGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$976K Hold
8,287
– – 0.14% 114
2025
Q4 		$1.36M Sell
8,287
-2,184
-21% -$342K 0.18% 88
2025
Q3 		$1.4M Sell
10,471
-10,472
-50% -$1.27M 0.19% 88
2025
Q2 		$2.6M Buy
+20,943
New +$2.67M 0.4% 45

Other funds holding RGEN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
UCFA
United Capital Financial Advisors Irving, Texas $16.3B AUM 16.34% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Glen Eagle Advisors's RGEN Position: Q1 2026 in Review

Glen Eagle Advisors held its Repligen (RGEN) position steady in Q1 2026 at 8,287 shares worth $976K. The position accounts for 0.14% of the portfolio, ranked #114.

Glen Eagle Advisors first reported a position in RGEN in Q2 2025 and has held it in 4 quarters since. The position peaked at $2.6M in Q2 2025. 441 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.

  • Glen Eagle Advisors held 8,287 shares of Repligen worth $976K as of Q1 2026.
  • Glen Eagle Advisors left its Repligen share count unchanged in Q1 2026.
  • Repligen made up 0.14% of Glen Eagle Advisors's portfolio in Q1 2026, its #114 holding.
  • Glen Eagle Advisors first reported a position in Repligen in Q2 2025 and has held it in 4 quarters since.
  • Glen Eagle Advisors's Repligen position peaked at $2.6M in Q2 2025.
  • 441 funds tracked by Wall St. Rank held Repligen as of Q1 2026.

Based on Glen Eagle Advisors's 13F filing for Q1 2026, filed 15 May 2026.